Results 241 to 250 of about 18,511,006 (302)

When Nature Counts: Corporate Biodiversity Attention and Access to Bank Finance

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT This paper investigates whether corporate attention to biodiversity influences firms' access to bank loans, an overlooked question in the emerging biodiversity–finance literature. Using a novel, text‐based measure constructed from 446 biodiversity‐related keywords and applied to Chinese A‐share listed firms from 2000 to 2023, we show that ...
Ruxiao Li   +3 more
wiley   +1 more source

The Health of Nations Fund: Financing global drug development. [PDF]

open access: yesPLOS Glob Public Health
Cho J   +4 more
europepmc   +1 more source

The Impact of Green Innovation and Green Finance on Corporate ESG Performance

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT Amid the transition towards a low‐carbon economy and the pursuit of sustainable development goals, ESG performance has become a key indicator of long‐term corporate sustainability. Drawing on data from Chinese A‐share listed companies between 2012 and 2022, this study examines how green innovation and green finance affect corporate ESG ...
Zhaoke Feng, Chaminda Wijethilake
wiley   +1 more source

The Governance Gap: Democratizing Drug Development Through Decision Architecture. [PDF]

open access: yesClin Pharmacol Ther
Rayner CR   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy